Jyoti Structures Limited on January 19, 2022, in Business Standard and Apala Mahanagar Newspapers with regard to following Financial Results: Standalone & Consolidated Unaudited Financial Results together with its Limited Review Report for the Quarter Ended September 30, 2021
Eris Lifesciences Limited has informed the Exchange about Schedule of meet
Iifl Wealth Management Limited has informed the Exchange regarding Allotment of 10468 Shares.
Cigniti Technologies Limited has informed the Exchange about Copy of Newspaper Publication
Poddar Housing and Development Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Hindustan Media Ventures Limited has informed the Exchange about Copy of Newspaper Publication
Virescent Renewable Energy Trust has informed the Exchange regarding Corporate Governance Compliance Report for the quarter ended on December 31, 2021.
Tata Teleservices (Maharashtra) Limited has informed the Exchange about Loss of Share Certificates
Fineotex Chemical Limited has informed the Exchange about Investor Presentation
Cadila Healthcare Limited has informed the Exchange regarding a press release dated January 20, 2022, titled Zydus receives final approval from USFDA for Vigabatrin Tablets.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
